HBM vs. AVDL

Last updated Jun 9, 2026

HBM (Hudbay Minerals Inc.) and AVDL (Avadel Pharmaceuticals plc) are both stocks. HBM operates in Copper (Basic Materials), while AVDL operates in Drug Manufacturers - Specialty & Generic (Healthcare). At a 0.14 correlation, their price movements are largely independent.

Performance

HBM vs. AVDL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Hudbay Minerals Inc. (HBM) and Avadel Pharmaceuticals plc (AVDL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

HBM

• 1D: 1.75%
• 1M: 4.36%
• YTD: 31.58%
• 6M: 50.45%
• 1Y: 171.66%
• 3Y*: 77.46%
• 5Y*: 30.42%
• 10Y*: 18.60%

AVDL

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HBM vs. AVDL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
HBM Hudbay Minerals Inc.	31.58%	145.46%	47.03%	9.24%	-29.87%	3.82%	69.50%	-11.77%	-46.20%	54.77%
AVDL Avadel Pharmaceuticals plc	0.42%	105.04%	-25.57%	97.21%	-11.39%	20.96%	-11.52%	192.64%	-68.54%	-21.08%

Correlation

The correlation between HBM and AVDL is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.03
Correlation (3Y) Calculated over the trailing 3-year period	0.13
Correlation (5Y) Calculated over the trailing 5-year period	0.17
Correlation (10Y) Calculated over the trailing 10-year period	0.14
Correlation (All Time) Calculated using the full available price history since Feb 13, 2009	0.14

The correlation between HBM and AVDL shifts across timeframes, from 0.03 (1 year) to 0.17 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap HBM : $10.41B AVDL : $2.19B
EPS HBM : $1.65 AVDL : -$0.00
PS Ratio HBM : 4.39 AVDL : 8.72
PB Ratio HBM : 2.94 AVDL : 22.31
Total Revenue (TTM) HBM : $2.37B AVDL : $248.52M
Gross Profit (TTM) HBM : $828.54M AVDL : $234.76M
EBITDA (TTM) HBM : $1.54B AVDL : $10.13M

Return for Risk

HBM vs. AVDL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HBM

HBM Risk / Return Rank: 92
HBM Sharpe Ratio Rank: 95
HBM Sortino Ratio Rank: 90
HBM Omega Ratio Rank: 90
HBM Calmar Ratio Rank: 91
HBM Martin Ratio Rank: 93

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HBM vs. AVDL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Hudbay Minerals Inc. (HBM) and Avadel Pharmaceuticals plc (AVDL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HBM	AVDL	Difference
Sharpe ratio: Return per unit of total volatility	2.96	—	—
Sortino ratio: Return per unit of downside risk	3.09	—	—
Omega ratio: Gain probability vs. loss probability	1.41	—	—
Calmar ratio: Return relative to maximum drawdown	4.78	—	—
Martin ratio: Return relative to average drawdown	15.13	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	HBM	AVDL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.96	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.55	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.32	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.20	—	—

Drawdowns

Drawdown Indicators

	HBM	AVDL	Difference
Max Drawdown Largest peak-to-trough decline	-92.21%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-36.16%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-41.11%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-63.33%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-86.34%	—	—
Current Drawdown Current decline from peak	-18.07%	—	—
Average Drawdown Average peak-to-trough decline	-52.50%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	11.40%	—	—

Volatility

Volatility by Period

	HBM	AVDL	Difference
Volatility (1M) Calculated over the trailing 1-month period	25.29%	—	—
Volatility (6M) Calculated over the trailing 6-month period	46.90%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	58.55%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	55.36%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	58.79%	—	—

Dividends

HBM vs. AVDL - Dividend Comparison

HBM's dividend yield for the trailing twelve months is around 0.05%, while AVDL has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
AVDL Avadel Pharmaceuticals plc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
HBM Hudbay Minerals Inc.	0.05%	0.07%	0.17%	0.31%	0.32%	0.22%	0.21%	0.36%	0.38%	0.23%	0.35%	0.52%

Financials

Frequently Asked Questions

Can I hold both HBM and AVDL in my portfolio?

HBM and AVDL have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.